TY - JOUR
T1 - Rational Design in Photopharmacology with Molecular Photoswitches
AU - Kobauri, Piermichele
AU - Dekker, Frank J.
AU - Szymanski, Wiktor
AU - Feringa, Ben L.
N1 - Funding Information:
We kindly acknowledge financial support from the EU Horizon 2020 program (ALERT cofund no. 713482 for B.L.F.), the Dutch Scientific Organization (VIDI grant no. 723.014.001 for W.S.). We would like to thank Martyna Komorowska for the design and creation of frontispiece and TOC graphics.
Publisher Copyright:
© 2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.
PY - 2023/7/24
Y1 - 2023/7/24
N2 - Photopharmacology is an attractive approach for achieving targeted drug action with the use of light. In photopharmacology, molecular photoswitches are introduced into the structure of biologically active small molecules to allow for the optical control of their potency. Going beyond trial and error, photopharmacology has progressively applied rational drug design methodologies to devise light-controlled bioactive ligands. In this review, we categorize photopharmacological efforts from the standpoint of medicinal chemistry strategies, focusing on diffusible photochromic ligands modified with photoswitches that operate through E-Z bond isomerization. In the vast majority of cases, photoswitchable ligands are designed as analogs of existing compounds, through a variety of approaches. By analyzing in detail a comprehensive list of instructive examples, we describe the state of the art and discuss future opportunities for rational design in photopharmacology.
AB - Photopharmacology is an attractive approach for achieving targeted drug action with the use of light. In photopharmacology, molecular photoswitches are introduced into the structure of biologically active small molecules to allow for the optical control of their potency. Going beyond trial and error, photopharmacology has progressively applied rational drug design methodologies to devise light-controlled bioactive ligands. In this review, we categorize photopharmacological efforts from the standpoint of medicinal chemistry strategies, focusing on diffusible photochromic ligands modified with photoswitches that operate through E-Z bond isomerization. In the vast majority of cases, photoswitchable ligands are designed as analogs of existing compounds, through a variety of approaches. By analyzing in detail a comprehensive list of instructive examples, we describe the state of the art and discuss future opportunities for rational design in photopharmacology.
KW - Drug Design
KW - Medicinal Chemistry
KW - Photopharmacology
KW - Photoswitchable Molecule
UR - http://www.scopus.com/inward/record.url?scp=85156164390&partnerID=8YFLogxK
U2 - 10.1002/anie.202300681
DO - 10.1002/anie.202300681
M3 - Review article
AN - SCOPUS:85156164390
SN - 1433-7851
VL - 62
JO - Angewandte Chemie - International Edition
JF - Angewandte Chemie - International Edition
IS - 30
M1 - e202300681
ER -